2018-06-04 | News
Between 4 and 7 June this year, representatives of our Company are taking part in the largest global Life Sciences networking meeting. Our participation at this event is one of the elements of our implementing our strategy to increase Celon Pharma’s international presence and our planned global commercialisation of the Company’s innovative portfolio. Bogdan Manowski, DirectorRead more »
Celon Pharma S.A. is an integrated pharmaceutical company which conducts advanced research and manufactures modern drugs. The company is also a successful marketing authorisation holder for it products. The drugs we offer help thousands of patients lead a better and longer life.
In the German market, Salmex will be available under the trade name Salflutin. After completing the DCP registration procedure, the German drug registration authority will verify the national version of the information materials (including the leaflet, the medicine package) and will issue a final decision on marketing authorisation within the time limits set by theRead more »
Celon Pharma at WSE
People are the key to the success of all projects. We know this well and we would also like you to learn this first hand. As a Celon Pharma S.A. employee, you will be provided with an attractive salary, in-depth training and an incentive system. What is equally important, you will have the satisfaction of working with modern and essential drugs which save and extend human life.